Ureaplasma parvum infection alters filamin a dynamics in host cells

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Allam, Ayman B ^a   Alvarez, Sophie ^b,c   Brown, Mary B ^a   Reyes, Leticia ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c DONALD DANFORTH PLANT SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ALPHA ENOLASE; APOLIPOPROTEIN A 1 PRECURSOR; CALMODULIN; CALPAIN; CALPASTATIN; COMPLEMENT 3 PRECURSOR; CREATINE KINASE; CREATINE KINASE B TYPE; EH DOMAIN CONTAINING 2 PROTEIN; ELONGATION FACTOR 1ALPHA; FILAMIN A; ISOCITRATE DEHYDROGENASE (NADP); PEPTIDYL CIS TRANS ISOMERASE B PRECURSOR; PEROXIREDOXIN 2; PROFILIN; PROFILIN I; PROTEIN; PROTEIN PRECURSOR; SERINE; SPECTRIN; TALIN; UNCLASSIFIED DRUG; VINCULIN; ACTIN BINDING PROTEIN; CONTRACTILE PROTEIN; FILAMINS;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BENIGN PROSTATE HYPERPLASTIC CELL; BLADDER; CELL FUNCTION; CELL LINE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOCAL ADHESION; HOST CELL; HOST PATHOGEN INTERACTION; IMMUNOBLOTTING; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UREAPLASMA; UREAPLASMA PARVUM; ANIMAL; DISEASE MODEL; FISCHER 344 RAT; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; UREAPLASMA INFECTION; URINARY TRACT INFECTION;

ANIMALS; CELL LINE; CONTRACTILE PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; MICROFILAMENT PROTEINS; PHOSPHORYLATION; RATS; RATS, INBRED F344; UREAPLASMA; UREAPLASMA INFECTIONS; URINARY BLADDER; URINARY TRACT INFECTIONS;

EID: 79954589604     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-101     Document Type: Article

References (49)

1. Volgmann T, Ohlinger R, Panzig B. Ureaplasma urealyticum-harmless commensal or underestimated enemy of human reproduction? A review. Archives of gynecology and obstetrics 2005, 273(3):133-139. 10.1007/s00404-005-0030-1, 16044191.
2. Waites KB, Schelonka RL, Xiao L, Grigsby PL, Novy MJ. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Seminars in fetal & neonatal medicine 2009, 14(4):190-199. 10.1016/j.siny.2008.11.009, 21115413.
3. Yi J, Yoon BH, Kim EC. Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. Molecular and cellular probes 2005, 19(4):255-260. 10.1016/j.mcp.2005.04.002, 16005182.
4. Schelonka RL, Waites KB. Ureaplasma infection and neonatal lung disease. Semin Perinatol 2007, 31(1):2-9. 10.1053/j.semperi.2007.01.001, 17317421.
5. Pinna GS, Skevaki CL, Kafetzis. The significance of Ureaplasma urealyticum as a pathogenic agent in the paediatric population. Curr Opin Infect Dis 2006, 19(3):283-289. 10.1097/01.qco.0000224824.73223.e7, 16645491.
6. McDonald MI, Lam MH, Birch DF, D'Arcy AF, Fairley KF, Pavillard ER. Ureaplasma urealyticum in patients with acute symptoms of urinary tract infection. The Journal of urology 1982, 128(3):517-519.
7. Giannakopoulos S, Alivizatos G, Deliveliotis C, Skolarikos A, Kastriotis J, Sofras F. Encrusted cystitis and pyelitis. Eur Urol 2001, 39(4):446-448. 10.1159/000052483, 11306884.
8. Taylor-Robinson D, Csonka GW, Prentice MJ. Human intra-urethral inoculation of ureplasmas. Q J Med 1977, 46(183):309-326.
9. Skerk V, Marekovic I, Markovinovic L, Begovac J, Skerk V, Barsic N, Majdak-Gluhinic V. Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum. Chemotherapy 2006, 52(1):9-11. 10.1159/000090234, 16340190.
10. Hedelin H. Uropathogens and urinary tract concretion formation and catheter encrustations. International journal of antimicrobial agents 2002, 19(6):484-487. 10.1016/S0924-8579(02)00095-X, 12135838.
11. Reyes L, Alvarez S, Allam A, Reinhard M, Brown MB. Complicated urinary tract infection is associated with uroepithelial expression of proinflammatory protein S100A8. Infection and immunity 2009, 77(10):4265-4274. 10.1128/IAI.00458-09, 2747944, 19667050.
12. Reyes L, Reinhard M, Brown MB. Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation. BMC infectious diseases 2009, 9:9. 10.1186/1471-2334-9-9, 2656517, 19171043.
13. Reyes L, Reinhard M, O'Donell L J, Stevens J, Brown MB. Rat strains differ in susceptibility to Ureaplasma parvum-induced urinary tract infection and struvite stone formation. Infection and immunity 2006, 74(12):6656-6664. 10.1128/IAI.00984-06, 1698052, 16982825.
14. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci USA 2000, 97(16):8829-8835. 10.1073/pnas.97.16.8829, 34019, 10922042.
15. Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infection and immunity 2009, 78(2):568-585. 2812207, 19917708.
16. Popowicz GM, Schleicher M, Noegel AA, Holak TA. Filamins: promiscuous organizers of the cytoskeleton. Trends in biochemical sciences 2006, 31(7):411-419. 10.1016/j.tibs.2006.05.006, 16781869.
17. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, Shapiro SS. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2001, 2(2):138-145. 10.1038/35052082, 11252955.
18. Kersey PJ, Duarte J, Williams A, Karavidopoulou Y, Birney E, Apweiler R. The International Protein Index: an integrated database for proteomics experiments. Proteomics 2004, 4(7):1985-1988. 10.1002/pmic.200300721, 15221759.
19. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL, Nuwaysir LM, Schaeffer DA. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 2007, 6(9):1638-1655. 10.1074/mcp.T600050-MCP200, 17533153.
20. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In vitro cellular & developmental biology 1995, 31(1):14-24. 10.1007/BF02631333, 21516490.
21. Mitchell S, Abel P, Ware M, Stamp G, Lalani E. Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU international 2000, 85(7):932-944.
22. Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N, Rosser CJ, Tyson DR, et al. Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One 2009, 4(9):e6872. 10.1371/journal.pone.0006872, 2730529, 19721714.
23. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, et al. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res 2009, 15(3):788-796. 10.1158/1078-0432.CCR-08-1402, 2666194, 19188148.
24. Loy CJ, Sim KS, Yong EL, Yoshida N, Ogata T, Tanabe K, Li S, Nakazato M, Kohu K, Takafuta T, et al. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 2003, 100(8):4562-4567. 10.1073/pnas.0736237100, 153595, 12682292.
25. Elkind E, Rechnitzer H, Vaisid T, Kornspan JD, Barnoy S, Rottem S, Kosower NS. Mycoplasma hyorhinis upregulates calpastatin and inhibits calpain-dependent proteolysis in SH-SY5Y neuroblastoma cells. FEMS microbiology letters 2010, 304(1):62-68. 10.1111/j.1574-6968.2009.01893.x, 20100284.
26. Garcia E, Stracher A, Jay D. Calcineurin dephosphorylates the C-terminal region of filamin in an important regulatory site: a possible mechanism for filamin mobilization and cell signaling. Archives of biochemistry and biophysics 2006, 446(2):140-150. 10.1016/j.abb.2005.12.006, 16442073.
27. Blase C, Becker D, Kappel S, Bereiter-Hahn J. Microfilament dynamics during HaCaT cell volume regulation. European journal of cell biology 2009, 88(3):131-139. 10.1016/j.ejcb.2008.10.003, 19036471.
28. Schnittler HJ, Schneider SW, Raifer H, Luo F, Dieterich P, Just I, Aktories K. Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress. Pflugers Arch 2001, 442(5):675-687. 10.1007/s004240100589, 11512023.
29. Jockusch BM, Murk K, Rothkegel M, Yarmola EG, Bubb MR. The profile of profilins How depolymerization can promote polymerization: the case of actin and profilin. Rev Physiol Biochem Pharmacol 2007, 159(11):131-149.
30. Mierke CT. The role of vinculin in the regulation of the mechanical properties of cells. Cell Biochem Biophys 2009, 53(3):115-126. 10.1007/s12013-009-9047-6, 19350419.
31. Campbell ID. Studies of focal adhesion assembly. Biochem Soc Trans 2008, 36(Pt 2):263-266.
32. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009, 229(1):12-26. 10.1111/j.1600-065X.2009.00770.x, 19426212.
33. Leonardi A, Ellinger-Ziegelbauer H, Franzoso G, Brown K, Siebenlist U. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. J Biol Chem 2000, 275(1):271-278. 10.1074/jbc.275.1.271, 10617615.
34. Marti A, Luo Z, Cunningham C, Ohta Y, Hartwig J, Stossel TP, Kyriakis JM, Avruch J. Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells. J Biol Chem 1997, 272(5):2620-2628. 10.1074/jbc.272.5.2620, 9006895.
35. Wang Q, Patton WF, Chiang ET, Hechtman HB, Shepro D. Filamin translocation is an early endothelial cell inflammatory response to bradykinin: regulation by calcium, protein kinases, and protein phosphatases. J Cell Biochem 1996, 62(3):383-396. 10.1002/(SICI)1097-4644(199609)62:3<383::AID-JCB8>3.0.CO;2-N, 8872609.
36. van der Flier A, Sonnenberg A. Structural and functional aspects of filamins. Biochim Biophys Acta 2001, 1538(2-3):99-117. 10.1016/S0167-4889(01)00072-6, 11336782.
37. Jay D, Garcia EJ, de la Luz Ibarra M. In situ determination of a PKA phosphorylation site in the C-terminal region of filamin. Mol Cell Biochem 2004, 260:49-53.
38. Melloni E, Michetti M, Salamino F, Minafra R, Sparatore B, Pontremoli S. Isolation and characterization of calpain activator protein from bovine brain. Methods in molecular biology 2000, 144:99-105.
39. Stifanese R, Averna M, Salamino F, Cantoni C, Mingari MC, Prato C, Pontremoli S, Melloni E. Characterization of the calpain/calpastatin system in human hemopoietic cell lines. Archives of biochemistry and biophysics 2006, 456:48-57. 10.1016/j.abb.2006.09.022, 17084378.
40. Pilop C, Aregger F, Gorman RC, Brunisholz R, Gerrits B, Schaffner T, Gorman JH, Matyas G, Carrel T, Frey BM. Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation 2009, 120(11):983-991. 10.1161/CIRCULATIONAHA.108.843516, 19720936.
41. Averna M, de Tullio R, Passalacqua M, Salamino F, Pontremoli S, Melloni E. Changes in intracellular calpastatin localization are mediated by reversible phosphorylation. The Biochemical journal 2001, 354(Pt 1):25-30. 1221624, 11171075.
42. Averna M, Stifanese R, De Tullio R, Defranchi E, Salamino F, Melloni E, Pontremoli S. Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells. The FEBS journal 2006, 273(8):1660-1668. 10.1111/j.1742-4658.2006.05180.x, 16623703.
43. Woo MS, Ohta Y, Rabinovitz I, Stossel TP, Blenis J. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Molecular and cellular biology 2004, 24:3025-3035. 10.1128/MCB.24.7.3025-3035.2004, 371131, 15024089.
44. Marjanovic S, Wollberg P, Skog S, Heiden T, Nelson BD. The effects of cAMP on the expression of glycolytic isozymes in activated peripheral human T lymphocytes. Archives of biochemistry and biophysics 1993, 302(2):398-401. 10.1006/abbi.1993.1230, 8387745.
45. Porter SE, Dwyer-Nield LD, Malkinson AM. Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme. Am J Physiol Lung Cell Mol Physiol 2001, 280(6):L1282-1289.
46. Della Fazia MA, Castelli M, Bartoli D, Pieroni S, Pettirossi V, Piobbico D, Viola-Magni M, Servillo G. HOPS: a novel cAMP-dependent shuttling protein involved in protein synthesis regulation. J Cell Sci 2005, 118(Pt 14):3185-3194.
47. Swaney JS, Patel HH, Yokoyama U, Head BP, Roth DM, Insel PA. Focal adhesions in (myo)fibroblasts scaffold adenylyl cyclase with phosphorylated caveolin. J Biol Chem 2006, 281(25):17173-17179. 10.1074/jbc.M513097200, 16618703.
48. Gloerich M, Ponsioen B, Vliem MJ, Zhang Z, Zhao J, Kooistra MR, Price LS, Ritsma L, Zwartkruis FJ, Rehmann H, et al. Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. Molecular and cellular biology 30(22):5421-5431.
49. Wall EA, Zavzavadjian JR, Chang MS, Randhawa B, Zhu X, Hsueh RC, Liu J, Driver A, Bao XR, Sternweis PC, et al. Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105. Sci Signal 2009, 2(75):ra28. 10.1126/scisignal.2000202, 2770900, 19531803.